spacer
spacer

PDBsum entry 2xc0

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Blood clotting PDB id
2xc0

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
235 a.a. *
45 a.a. *
Ligands
8NC
Metals
_NA
_CA
Waters ×188
* Residue conservation analysis
PDB id:
2xc0
Name: Blood clotting
Title: Factor xa in complex with a pyrrolidine-3,4-dicarboxylic acid inhibitor
Structure: Activated factor xa heavy chain. Chain: a. Fragment: heavy chain, residues 235-475. Engineered: yes. Factor x light chain. Chain: l. Fragment: lightchain, residues 126-180. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
Resolution:
2.05Å     R-factor:   0.187     R-free:   0.240
Authors: D.W.Banner,J.Benz,D.Schlatter,L.Anselm,W.Haap
Key ref: L.Anselm et al. (2010). Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate. Bioorg Med Chem Lett, 20, 5313-5319. PubMed id: 20650636
Date:
15-Apr-10     Release date:   04-Aug-10    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00742  (FA10_HUMAN) -  Coagulation factor X from Homo sapiens
Seq:
Struc:
488 a.a.
235 a.a.
Protein chain
Pfam   ArchSchema ?
P00742  (FA10_HUMAN) -  Coagulation factor X from Homo sapiens
Seq:
Struc:
488 a.a.
45 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, L: E.C.3.4.21.6  - coagulation factor Xa.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.

 

 
Bioorg Med Chem Lett 20:5313-5319 (2010)
PubMed id: 20650636  
 
 
Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate.
L.Anselm, D.W.Banner, J.Benz, K.G.Zbinden, J.Himber, H.Hilpert, W.Huber, B.Kuhn, J.L.Mary, M.B.Otteneder, N.Panday, F.Ricklin, M.Stahl, S.Thomi, W.Haap.
 
  ABSTRACT  
 
No abstract given.

 

 

spacer

spacer